Esters of 4, 9-dihydroxy-naphtho [2, 3-b] furans for disease therapies
US9150530B2 · kind B2 · utility
10Cited by
1References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2011 |
| Grant date | Oct 6, 2015 |
| Priority date | — |
| Expiry date | Mar 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65517
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses esters of 4,9-dihydroxy-naphtho[2,3-b]furans and methods of making and using the same. The present invention also discloses conversion of the esters into therapeutically active 4,9-dihydroxy-naphtho[2,3-b]furans in vivo. The present invention furthermore discloses pharmaceutical compositions comprising the esters of 4,9-dihydroxy-naphtho[2,3-b]furans for the treatment of various indications including proliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.